Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 5.74%831.53M | ---- | 20.51%786.39M | ---- | 16.30%652.54M | ---- | 32.57%561.06M | ---- | 49.05%423.22M | ---- |
| Profit adjustment | ||||||||||
| Attributable subsidiary (profit) loss | -194.18%-3.39M | ---- | 86.43%-1.15M | ---- | -147.27%-8.48M | ---- | -171.93%-3.43M | ---- | -125.18%-1.26M | ---- |
| Impairment and provisions: | 431.72%57.21M | ---- | -55.68%10.76M | ---- | 18.49%24.28M | ---- | 68.79%20.49M | ---- | 5.65%12.14M | ---- |
| -Impairmen of inventory (reversal) | --16.74M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | 276.14%40.47M | ---- | -55.68%10.76M | ---- | 18.49%24.28M | ---- | 68.79%20.49M | ---- | 5.65%12.14M | ---- |
| Revaluation surplus: | -179.61%-4.54M | ---- | ---1.62M | ---- | ---- | ---- | 60.78%-160K | ---- | 47.69%-408K | ---- |
| -Other fair value changes | -179.61%-4.54M | ---- | ---1.62M | ---- | ---- | ---- | 60.78%-160K | ---- | 47.69%-408K | ---- |
| Asset sale loss (gain): | -8.97%416K | ---- | 41.49%457K | ---- | 204.72%323K | ---- | -79.77%106K | ---- | 819.30%524K | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | --15K | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | -8.97%416K | ---- | 48.38%457K | ---- | 190.57%308K | ---- | -79.77%106K | ---- | 819.30%524K | ---- |
| Depreciation and amortization: | 60.09%28.98M | ---- | 29.44%18.1M | ---- | 76.12%13.99M | ---- | 30.12%7.94M | ---- | 2.88%6.1M | ---- |
| -Other depreciation and amortization | 60.09%28.98M | ---- | 29.44%18.1M | ---- | 76.12%13.99M | ---- | 30.12%7.94M | ---- | 2.88%6.1M | ---- |
| Financial expense | -13.11%106K | ---- | -81.14%122K | ---- | -76.42%647K | ---- | 298.26%2.74M | ---- | 27.36%689K | ---- |
| Exchange Loss (gain) | ---- | ---- | ---- | ---- | 2,050.47%8.31M | ---- | 47.67%-426K | ---- | -196.56%-814K | ---- |
| Special items | 11.31%-71.2M | ---- | -19.09%-80.27M | ---- | -51.15%-67.4M | ---- | -35.70%-44.59M | ---- | -6.10%-32.86M | ---- |
| Operating profit before the change of operating capital | 14.51%839.13M | ---- | 17.40%732.79M | ---- | 14.80%624.2M | ---- | 33.49%543.74M | ---- | 50.58%407.33M | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -31.85%-59.73M | ---- | 53.42%-45.3M | ---- | -42.04%-97.25M | ---- | -153.71%-68.47M | ---- | -44.59%-26.99M | ---- |
| Accounts receivable (increase)decrease | -534.13%-210.61M | ---- | ---33.21M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Accounts payable increase (decrease) | 71.56%272.99M | ---- | -8.82%159.12M | ---- | -2.23%174.52M | ---- | 691.92%178.49M | ---- | -85.55%22.54M | ---- |
| Special items for working capital changes | 2,117.00%218.28M | ---- | -102.66%-10.82M | ---- | -27.50%406.29M | ---- | 964.79%560.41M | ---- | -278.99%-64.8M | ---- |
| Cash from business operations | 32.08%1.06B | 59.17%509.06M | -27.55%802.57M | -57.82%319.82M | -8.76%1.11B | 40.15%758.15M | 259.14%1.21B | 243.49%540.95M | -7.65%338.08M | -14.81%157.49M |
| China income tax paid | 4.16%-231.32M | 25.97%-110.12M | -34.94%-241.36M | -42.38%-148.75M | -96.01%-178.86M | -49.28%-104.48M | 4.64%-91.25M | -13.21%-69.98M | -97.88%-95.69M | -46.56%-61.82M |
| Net cash from operations | 47.67%828.74M | 133.21%398.95M | -39.58%561.21M | -73.83%171.07M | -17.28%928.89M | 38.79%653.67M | 363.28%1.12B | 392.30%470.96M | -23.72%242.39M | -32.95%95.67M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 4.71%50.45M | 23.27%26.54M | 24.02%48.18M | 0.23%21.53M | -19.33%38.85M | 0.38%21.48M | 159.03%48.15M | 11.61%21.4M | 26.77%18.59M | 9.94%19.17M |
| Dividend received - investment | -63.53%3.06M | 0.00%1.53M | 448.37%8.39M | 0.00%1.53M | --1.53M | --1.53M | ---- | ---- | ---- | ---- |
| Decrease in deposits (increase) | 17.52%-284.77M | 122.93%72.54M | 70.92%-345.27M | 47.27%-316.36M | -6,263.57%-1.19B | -329.32%-600M | -122.39%-18.66M | -791.14%-139.76M | 132.67%83.32M | -77.33%20.22M |
| Sale of fixed assets | -95.76%357K | -98.61%48K | 739.38%8.42M | 688.36%3.45M | 48.81%1M | 317.14%438K | -32.53%674K | --105K | --999K | ---- |
| Purchase of fixed assets | -33.98%-34.84M | -26.86%-13.37M | -4.64%-26M | 0.84%-10.54M | -14.18%-24.85M | -18.77%-10.63M | -67.93%-21.76M | -30.90%-8.95M | -58.08%-12.96M | -361.44%-6.83M |
| Sale of subsidiaries | 45.33%-492K | ---- | -22.62%-900K | ---900K | ---734K | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---3.2M | ---- | ---- | ---- | 40.35%-340K | ---- | -129.84%-570K | ---- | ---248K | ---- |
| Recovery of cash from investments | --451.62M | --223.05M | ---- | ---- | ---- | ---- | 40.13%126.2M | -60.34%24.2M | -45.01%90.06M | -56.01%61.03M |
| Cash on investment | -92.12%-578.23M | -314.81%-420M | -75,145.00%-300.98M | ---101.25M | 99.61%-400K | ---- | 10.69%-102M | ---- | 30.97%-114.21M | 56.78%-60.7M |
| Other items in the investment business | ---- | ---- | ---- | ---- | --4M | --4M | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 34.88%-396.05M | 72.76%-109.66M | 47.94%-608.17M | 30.98%-402.53M | -3,745.39%-1.17B | -466.23%-583.18M | -51.12%32.04M | -413.18%-102.99M | 61.44%65.55M | -68.21%32.89M |
| Net cash before financing | 1,021.56%432.69M | 224.98%289.29M | 80.37%-46.95M | -428.34%-231.46M | -120.71%-239.24M | -80.84%70.5M | 275.07%1.15B | 186.24%367.97M | -14.07%307.94M | -47.77%128.55M |
| Cash flow from financing activities | ||||||||||
| Interest paid - financing | 13.11%-106K | -4.84%-65K | -106.78%-122K | -12.73%-62K | 21.33%-59K | ---55K | 44.85%-75K | ---- | 22.29%-136K | ---- |
| Dividends paid - financing | 15.26%-432.24M | 99.98%-78K | -95.15%-510.08M | ---347.97M | -135.36%-261.38M | ---- | 49.20%-111.06M | 15.63%-111.06M | -172.90%-218.63M | -64.31%-131.63M |
| Absorb investment income | -70.55%2.64M | -31.97%2M | 32.14%8.95M | --2.94M | 303.33%6.78M | ---- | -87.04%1.68M | ---- | 15.00%12.96M | ---- |
| Other items of the financing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -23.10%-1.12M | ---- | -232.97%-909K |
| Net cash from financing operations | 14.11%-432.1M | 100.29%1.02M | -96.66%-503.11M | -38,961.89%-346.48M | -129.74%-255.82M | 99.21%-887K | 46.50%-111.35M | 15.36%-112.18M | -188.86%-208.13M | -64.88%-132.54M |
| Effect of rate | 95.02%-730K | 98.70%-134K | -2,776.64%-14.67M | -8,685.83%-10.3M | 3.20%548K | -83.87%120K | -2.03%531K | -48.51%744K | -77.30%542K | -36.54%1.45M |
| Net Cash | 100.11%593K | 150.23%290.31M | -11.11%-550.06M | -930.28%-577.94M | -147.44%-495.06M | -72.79%69.61M | 945.60%1.04B | 6,512.48%255.79M | -65.14%99.81M | -102.41%-3.99M |
| Begining period cash | -38.80%890.66M | -38.80%890.66M | -25.36%1.46B | -25.36%1.46B | 115.28%1.95B | 115.28%1.95B | 12.46%905.75M | 12.46%905.75M | 55.87%805.39M | 55.87%805.39M |
| Cash at the end | -0.02%890.52M | 36.18%1.18B | -38.80%890.66M | -57.06%867.14M | -25.36%1.46B | 73.76%2.02B | 115.28%1.95B | 44.77%1.16B | 12.46%905.75M | 17.25%802.85M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.